Adding the percentage of VDAC1+CPT1a+ myeloid cells, pDCs, and H3K27Me3+VDAC1+CD4+ improved prediction of COVID-19 severity compared with basic clinical information (Figure S7C), highlighting the important contribution of the immune cell populations identified to disease severity. Here, CPT1A is linked to COVID-19.